Skip to content

Clinical trials

Phase 2 Sepsis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sepsis Phase: Phase 2 Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20191
20213
20222
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status4
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zhujiang Hospital2
Bin Du1
CHEN De-chang1
Dongzhimen Hospital, Beijing1
Grand Medical Pty Ltd.1
Lin Chen1
Novartis Pharmaceuticals1
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.1
Suzhou Yabao Pharmaceutical R&D Co., Ltd.1
Tianjin Chasesun Pharmaceutical Co., LTD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis12
Respiratory Distress Syndrome3
Shock, Septic2
Acute Kidney Injury1
Acute Lung Injury1
Autonomic Nervous System Diseases1
Cytokine Release Syndrome1
Wounds and Injuries1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.